Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
Gynecol Oncol
; 140(3): 565-74, 2016 Mar.
Article
en En
| MEDLINE
| ID: mdl-26812021
ABSTRACT
Obstetrician/gynecologists and gynecologic oncologists serve an integral role in the care of women at increased hereditary risk of cancer. Their contribution includes initial identification of high risk patients, screening procedures like bimanual exam, trans-vaginal ultrasound and endometrial biopsy, prophylaxis via TAH and/or BSO, and chemoprevention. Further, gynecologists also serve a central role in the management of the secondary repercussions of efforts to mitigate increased cancer risks, including vasomotor symptoms, sexual function, bone health, cardiovascular disease, and mental health. The past several years has seen multiple new high and moderate penetrance genes introduced into the clinical care of women at increased risk of gynecologic malignancy. Awareness of these new genes and the availability of new multi-gene panel tests is critical for providers on the front-line of women's health.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Neoplasias Colorrectales Hereditarias sin Poliposis
/
Pruebas Genéticas
/
Genes BRCA1
/
Genes BRCA2
/
Neoplasias de los Genitales Femeninos
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Idioma:
En
Revista:
Gynecol Oncol
Año:
2016
Tipo del documento:
Article